AAAAAA
Results:
1-22
|
Results: 22
Authors:
CHESON BD
SORENSEN JM
VENA DA
MONTELLO MJ
BARRET JA
DAMASIO E
TALLMAN M
ANNINO L
CONNERS J
COIFFIER B
LAURIA F
Citation: Bd. Cheson et al., TREATMENT OF HAIRY-CELL LEUKEMIA WITH 2-CHLORODEOXYADENOSINE VIA THE GROUP-C PROTOCOL MECHANISM OF THE NATIONAL-CANCER-INSTITUTE - A REPORTOF 979 PATIENTS, Journal of clinical oncology, 16(9), 1998, pp. 3007-3015
Authors:
POCALYKO DJ
TALLMAN M
Citation: Dj. Pocalyko et M. Tallman, EFFECTS OF AMPHIPATHS ON THE ACTIVITY AND STABILITY OF FUSARIUM-SOLANI PISI CUTINASE, Enzyme and microbial technology, 22(7), 1998, pp. 647-651
Authors:
YOUNG D
TALLMAN M
LANDY K
YOUNG T
LUKAS D
LEWIS B
MCGUINNESS E
Citation: D. Young et al., OCULAR LENS NAD KINASE - PARTIAL-PURIFICATION AND METABOLIC IMPLICATIONS, Biochemical and biophysical research communications, 247(1), 1998, pp. 154-158
Authors:
MCGUINNESS E
YOUNG D
LANDY K
TALLMAN M
YOUNG T
LUKAS D
LEWIS B
Citation: E. Mcguinness et al., LENTICULAR NAD KINASE - PARTIAL-PURIFICATION AND METABOLIC IMPLICATIONS, The FASEB journal, 11(9), 1997, pp. 1903-1903
Authors:
GORDON MS
YOUNG ML
TALLMAN M
BENNETT J
PAIETTA E
CRIPE L
LONGO W
GERAD H
BANERJEE T
ROWE J
Citation: Ms. Gordon et al., PHASE-II TRIAL OF 2-CHLORODEOXYADENOSINE (2-CDA) IN PATIENTS (PTS) WITH RELAPSED REFRACTORY ACUTE MYELOID-LEUKEMIA (AML) - A STUDY OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG), E5995/, Blood, 90(10), 1997, pp. 3826-3826
Authors:
ADVANI R
SABA HI
TALLMAN M
ROWE JM
WIERNIK PH
RAMEK J
DUGAN K
LUM B
VILLENA J
SIKIC BI
DAVIS E
PAIETTA E
LITCHMAN M
GREENBERG P
Citation: R. Advani et al., TREATMENT OF POOR-PROGNOSIS AML WITH PSC833 PLUS MITOXANTRONE, ETOPOSIDE, CYTARABINE (PSC-MEC), Blood, 90(10), 1997, pp. 2260-2260
Authors:
WINTER JN
LAZARUS HM
RADEMAKER A
VILLA M
MANGAN C
TALLMAN M
JAHNKE L
GORDON L
NEWMAN S
BYRD K
COOPER BW
HORVATH N
CRUM E
STADTMAUER EA
CONKLIN E
BAUMAN A
MARTIN J
GOOLSBY C
GERSON SL
BENDER J
OGORMAN M
Citation: Jn. Winter et al., PHASE I II STUDY OF COMBINED GRANULOCYTE-COLONY-STIMULATING FACTOR AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ADMINISTRATION FOR THE MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS/, Journal of clinical oncology, 14(1), 1996, pp. 277-286
Authors:
BENNETT CL
GOLUB R
WATERS T
TALLMAN M
ROWE J
Citation: Cl. Bennett et al., ECONOMIC-ANALYSIS OF GM-CSF AS ADJUNCT THERAPY FOR ADULTS WITH AML, Blood, 88(10), 1996, pp. 825-825
TREATMENT OF REFRACTORY RELAPSED AML WITH PSC833 PLUS MITOXANTRONE, ETOPOSIDE, CYTARABINE (PSC-MEC)/
Authors:
ADVANI R
SABA H
ROWE JM
TALLMAN M
WIERNIK P
RAMEK J
DUGAN K
LITCHMAN M
DORR R
LUM B
SIKIC B
DAVIS E
PAIETTA E
GREENBERG P
Citation: R. Advani et al., TREATMENT OF REFRACTORY RELAPSED AML WITH PSC833 PLUS MITOXANTRONE, ETOPOSIDE, CYTARABINE (PSC-MEC)/, Blood, 88(10), 1996, pp. 847-847
Authors:
FINN WG
YELAVARTHI KK
GARGIULO PM
THANGAVELU M
GOOLSBY CL
TRAYNOR A
TALLMAN M
PETERSON L
Citation: Wg. Finn et al., KARYOTYPE PREDICTS MORPHOLOGY AND IMMUNOPHENOTYPE IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), Laboratory investigation, 72(1), 1995, pp. 110-110
Authors:
TALLMAN M
HAKIMIAN D
WHEATON S
KOPECKY K
WOLLINS E
FOUCAR K
CASSILETH P
HABERMANN T
GREVER M
PETERSON LC
Citation: M. Tallman et al., MINIMAL RESIDUAL DISEASE IN PATIENTS WITH HAIRY-CELL LEUKEMIA IN COMPLETE REMISSION - COMPARISON OF 2-CHLORODEOXYADENOSINE WITH 2-DEOXYCOFORMYCIN AND PREDICTION OF EARLY RELAPSE, Blood, 86(10), 1995, pp. 1390-1390
Authors:
TALLMAN M
HAKIMIAN D
ZANZIG C
RADEMAKER A
WOLLINS E
PETERSON L
Citation: M. Tallman et al., RELAPSE OF HAIRY-CELL LEUKEMIA 2-CHLORODEOXYADENOSINE - LONG-TERM FOLLOW-UP OF THE NORTHWESTERN UNIVERSITY EXPERIENCE, Blood, 86(10), 1995, pp. 2419-2419
Authors:
GALLAGHER R
WILLMAN C
SLACK J
ANDERSEN J
LI Y
VISWANATHA D
BLOOMFIELD C
APPLEBAUM F
SCHIFFER C
TALLMAN M
WIERNIK P
Citation: R. Gallagher et al., CORRELATION OF PML-RAR-ALPHA MESSENGER-RNA TYPE WITH PRETREATMENT CLINICAL CHARACTERISTICS AND ACHIEVEMENT OF COMPLETE REMISSION (CR) IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) - AN INTERGROUP LABORATORY STUDY, Blood, 86(10), 1995, pp. 2902-2902
Authors:
LI Y
ZELENT A
RAO S
ANDERSEN J
PAIETTA E
TALLMAN M
WIERNIK P
GALLAGHER R
Citation: Y. Li et al., RAR-ALPHA-2 AND RAR-ALPHA-2-PML MESSENGER-RNA EXPRESSION IN ACUTE PROMYELOCYTIC LEUKEMIA (APL), Blood, 86(10), 1995, pp. 2921-2921
Authors:
DYRDA S
TALLMAN M
HAKIMIAN D
PETERSON LC
Citation: S. Dyrda et al., IMMUNOHISTOCHEMICAL DETECTION OF MINIMAL RESIDUAL DISEASE CORRELATED WITH RELAPSE IN PATIENTS WITH HAIRY-CELL LEUKEMIA TREATED WITH 2-CHLORODEOXYADENOSINE (2-CDA), Laboratory investigation, 70(1), 1994, pp. 10000107-10000107
Authors:
WINTER J
JAHNKE L
RADEMAKER A
TALLMAN M
GORDON L
NEWMAN S
KAMINER L
VILLA M
BAUMAN A
BYRD K
Citation: J. Winter et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) BY CYCLOPHOSPHAMIDE (CYCLO) AND OR COLONY-STIMULATING FACTOR (CSF) - A COMPARATIVE-ANALYSIS, Blood, 84(10), 1994, pp. 10000739-10000739
Authors:
RICKLES FR
HAIR G
SCHMEIZL M
KWAAN H
LANOTTE M
TALLMAN M
Citation: Fr. Rickles et al., ALL-TRANS-RETINOIC ACID (ATRA) INHIBITS THE EXPRESSION OF TISSUE FACTOR IN HUMAN PROGRANULOCYTIC LEUKEMIA-CELLS, Thrombosis and haemostasis, 69(6), 1993, pp. 573-573
Authors:
TALLMAN M
GRAY R
BENNETT J
VARIAKOJIS D
ROBERT N
WOOD W
WIERNIK P
Citation: M. Tallman et al., LEUKEMOGENIC POTENTIAL OF ADJUVANT CHEMOTHERAPY FOR EARLY-STAGE BREAST-CANCER - THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP (ECOG) EXPERIENCE, Blood, 82(10), 1993, pp. 10000048-10000048
Authors:
LEE E
KUZEL T
SAMUELSON E
TALLMAN M
ROENIGK H
ROSEN S
Citation: E. Lee et al., PHASE-II TRIAL OF 2-CHLORODEOXYADENOSINE (2-CDA) FOR THE TREATMENT OFCUTANEOUS T-CELL LYMPHOMA (CTCL), Blood, 82(10), 1993, pp. 10000142-10000142
Authors:
HOFFMAN M
TALLMAN M
JANSON D
HAKIMIAN D
KUZEL T
GORDON L
RAI KR
Citation: M. Hoffman et al., 2-CHLORODEOXYADENOSINE (2-CDA) IS AN ACTIVE SALVAGE THERAPY IN INDOLENT NON-HODGKINS-LYMPHOMA (NHL), Blood, 82(10), 1993, pp. 10000142-10000142
Authors:
STADTMAUER E
SCHENKEIN D
MILLER K
SICKLES C
BIGGS D
POWLIS W
FRIEDENBERG W
WINTER J
TALLMAN M
LAZARUS H
Citation: E. Stadtmauer et al., GM-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS (PSC) AND GM-CSF POST INFUSION AFTER HIGH-DOSE MELPHALAN, CYCLOPHOSPHAMIDE AND TOTAL-BODY IRRADIATION (TBI) FOR ADVANCED RELAPSED MULTIPLE-MYELOMA, Blood, 82(10), 1993, pp. 10000264-10000264
Authors:
WINTER JN
MANGAN C
BYRD K
TALLMAN M
GORDON L
JAHNKE L
LAZARUS H
COOPER B
CRUM E
HORVATH N
STADTMAUER E
RADEMAKER A
VILLA M
CONKLIN E
MARTIN J
GOOLSBY C
OGORMAN M
Citation: Jn. Winter et al., COMBINED RG-CSF AND GM-CSF PRIMING OF PERIPHERAL-BLOOD STEM-CELL HARVESTS, Blood, 82(10), 1993, pp. 10000293-10000293
Risultati:
1-22
|